MedImpact-Onco360 Collaboration Addresses Unique Needs of Cancer Care

Press Releases published on October 17, 2013

October 14, 2013 11:00 AM Eastern Daylight Time

SAN DIEGO--(BUSINESS WIRE)--MedImpact Healthcare Systems, Inc., the nation’s largest privately held provider of pharmacy benefit management (PBM) services, and Onco360, the fastest-growing independent Oncology Pharmacy and Clinical Support Services company, today announced a joint collaboration focused on offering MedImpact clients a unique and effective solution for bending the cost curve and delivering quality and value-based Oncology pharmaceutical care.

This comprehensive Oncology collaboration is aimed at providing health benefit payers with a proven and effective Oncology Pharmacy program, which combines a cost-efficient dispensing model with clinical excellence.

“The cost of cancer care is projected to increase to nearly $175 billion by 2020,” said Greg Watanabe, President of MedImpact, “That is a four-fold increase in less than 10 years, and one of the biggest reasons why we have been working to develop this solution for our clients.”

(click below to read the rest of the article)

Article Source

Last modified: July 22, 2021